These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7725993)

  • 21. The contribution of cavernous body biopsy in the diagnosis and treatment of male impotence.
    Malovrouvas D; Petraki C; Constantinidis E; Petraki K; Antoniadis G; Constantinidis C; Kranidis A
    Histol Histopathol; 1994 Jul; 9(3):427-31. PubMed ID: 7981490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia.
    Gholami SS; Rogers R; Chang J; Ho HC; Grazziottin T; Lin CS; Lue TF
    J Urol; 2003 Apr; 169(4):1577-81. PubMed ID: 12629419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Phenotype modulation of smooth muscle in corpus cavernosum in penis tunica albuginea in diabetes mellitus with erectile dysfunction: experiment with rats].
    Wei AY; Cheng Y; Li YG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):3006-11. PubMed ID: 18261337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intracavernous injection of lipo prostaglandin E1 for the diagnosis of impotence: a comparative study with prostaglandin E1-CD].
    Yajima M; Baba K; Minagawa N; Kohno S; Haraguchi C; Iwamoto T; Osada T
    Hinyokika Kiyo; 1993 Mar; 39(3):289-92. PubMed ID: 8506803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study of duplex Doppler ultrasonography and dynamic cavernosometry by infusion in the diagnosis of arteriogenic impotence].
    Moncada Iribarren I; Jara Rascón J; Lledó García E; González Chamorro F; Rodríguez Fernández E; Hernández Fernández C
    Actas Urol Esp; 1996 Sep; 20(8):709-18; discussion 718-9. PubMed ID: 9019945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study of the role of intracavernous injection of vasoactive intestinal peptide (VIP) and phentolamine mesylate in the treatment of erectile dysfunction.
    McMahon CG
    Int J Impot Res; 1996 Dec; 8(4):233-6. PubMed ID: 8981173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants.
    Azadzoi KM; Schulman RN; Aviram M; Siroky MB
    J Urol; 2005 Jul; 174(1):386-93. PubMed ID: 15947695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Modern aspects of pathophysiology and prevention of erectile dysfunction and cavernous fibrosis after radical prostatectomy].
    Veliev EI; Vanin AF; Kotov SV; Shiahlo VK
    Urologiia; 2009; (2):46-51. PubMed ID: 19526874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic and cavernosal plasma levels of endothelin (1-21) during different penile conditions in healthy males and patients with erectile dysfunction.
    Becker AJ; Uckert S; Stief CG; Truss MC; Hartmann U; Jonas U
    World J Urol; 2001 Nov; 19(5):371-6. PubMed ID: 11760787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular impotence: focal or diffuse penile disease.
    Wespes E; Moreira de Goes P; Schulman C
    J Urol; 1992 Nov; 148(5):1435-6. PubMed ID: 1433544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of sexual impotency by intra-cavernous injections of prostaglandin E1. Report of 180 patients].
    Amar E; Kobelinsky M; Khoury R; Sarkis P; Bouyer I; Dauphin A; Delmas V; Boccon-Gibod L
    Prog Urol; 1993 Dec; 3(6):971-8. PubMed ID: 8305940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computerized analysis of smooth muscle fibers in potent and impotent patients.
    Wespes E; Goes PM; Schiffmann S; Depierreux M; Vanderhaeghen JJ; Schulman CC
    J Urol; 1991 Oct; 146(4):1015-7. PubMed ID: 1895415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of ultrastructural alterations in cavernous tissue with the clinical diagnosis vasculogenic impotence.
    Karadeniz T; Topsakal M; Aydogmus A; Gülgün C; Aytekin Y; Basak D
    Urol Int; 1996; 57(1):58-61. PubMed ID: 8840493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasculogenic impotence and cavernosal oxygen tension.
    Brow SL; Seftel AD; Strohl KP; Herbener TE
    Int J Impot Res; 2000 Feb; 12(1):19-22. PubMed ID: 10982308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cavernous oxygen tension in the patients with erectile dysfunction.
    Tarhan F; Kuyumcuoğlu U; Kolsuz A; Ozgül A; Cangüven O
    Int J Impot Res; 1997 Sep; 9(3):149-53. PubMed ID: 9315492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Physiopathology of erectile dysfunction due to cavernous venous insufficiency].
    Stief CG
    Ann Urol (Paris); 1991; 25(2):64-6. PubMed ID: 2064358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The synergism of penile venous surgery and oral sildenafil in treating patients with erectile dysfunction.
    Wen HS; Hsieh CH; Hsu GL; Kao YC; Ling PY; Huang HM; Wang CJ; Einhorn EF
    Int J Androl; 2005 Oct; 28(5):297-303. PubMed ID: 16128990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence based assessment of erectile dysfunction.
    Broderick GA
    Int J Impot Res; 1998 May; 10 Suppl 2():S64-73; discussion S77-9. PubMed ID: 9647964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Technetium-99m-labelled RBC erection penogram to differentiate psychogenic from vasculogenic impotence.
    Shen YY; Kao CH
    Urol Int; 1998 Oct; 61(1):27-31. PubMed ID: 9792979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Objective criteria in the long-term evaluation of penile venous surgery.
    Wespes E; Moreira de Goes P; Sattar AA; Schulman C
    J Urol; 1994 Sep; 152(3):888-90. PubMed ID: 8051744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.